Senate Passes Bill Enforcing Distributor Compliance With Combat Meth Act
This article was originally published in The Tan Sheet
Executive Summary
The Senate passed a bill Feb. 11 that requires distributors of pseudoephedrine-containing OTC drugs to sell only to retailers who verify they comply with the Combat Meth Act or who are registered with the DEA
You may also be interested in...
Capitol Hill In Brief
Omnibus stalls: Congress March 6 extends a continuing resolution to fund most federal agencies through March 11 at fiscal 2008 levels while the House and Senate continue deliberating an omnibus package covering the rest of fiscal 2009. The previous continuing resolution expired March 6 (1"The Tan Sheet" Oct. 6, 2008, p. 9). The House Feb. 25 passed a $410 billion dollar omnibus package, H.R. 1105, including $2.6 billion for FDA, but the bill has stalled in the Senate (2"The Tan Sheet" March 2, 2009, p. 9). Votes are expected March 9 on Republican amendments and March 10 on the Senate's version of the omnibus covering federal agencies other than the departments of Defense and Homeland Security, which were funded in separate legislation Congress enacted in 2008
Database Funding Needed To Sell Investigators On Combat Meth Enforcement
Adequate funding for electronic databases to track retail sales of pseudoephedrine products may be needed to convince law enforcement officials in states besieged by manufacturing of methamphetamine that current PSE sales restrictions are sufficient
DEA Seeks Chain Of Distribution Information For Pseudoephedrine
Importers of ephedrine, pseudoephedrine and phenylpropanolamine will have to provide the Drug Enforcement Administration with information on the foreign chain of distribution from the manufacturer to the importer, under a rule proposed by the agency in the March 31 Federal Register